DiscoverJACC Specialty JournalsJACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors
JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors

Update: 2024-09-11
Share

Description

Tom Marwick, MBBS, PhD, MPH and Sivatharshini Ramalingam, MD discuss discuss the study design and findings, as well as the future use and potential development of cardio-oncology specific risk scores for prediction of heart failure in cancer survivors.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors

JACC: CardioOncology Pulse - Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors